BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32932920)

  • 1. Recent Advances and Future Perspectives in the Development of Therapeutic Approaches for Neurodegenerative Diseases.
    Bowerman M
    Brain Sci; 2020 Sep; 10(9):. PubMed ID: 32932920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).
    Mukherjee S
    Heliyon; 2021 Dec; 7(12):e08518. PubMed ID: 34926857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostics of neurodegenerative disorders.
    Agrawal M; Biswas A
    Front Mol Biosci; 2015; 2():54. PubMed ID: 26442283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
    Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
    Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology.
    Santiago JA; Bottero V; Potashkin JA
    Front Aging Neurosci; 2017; 9():166. PubMed ID: 28611656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of Mitochondrial Dynamics in Neurodegenerative Diseases.
    Gao J; Wang L; Liu J; Xie F; Su B; Wang X
    Antioxidants (Basel); 2017 Apr; 6(2):. PubMed ID: 28379197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
    Cho IK; Yang B; Forest C; Qian L; Chan AWS
    PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression in neurodegenerative diseases: Common mechanisms and current treatment options.
    Galts CPC; Bettio LEB; Jewett DC; Yang CC; Brocardo PS; Rodrigues ALS; Thacker JS; Gil-Mohapel J
    Neurosci Biobehav Rev; 2019 Jul; 102():56-84. PubMed ID: 30995512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases.
    Ni Z; Chen R
    Transl Neurodegener; 2015; 4():22. PubMed ID: 26579223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac electrical remodeling and neurodegenerative diseases association.
    Joviano-Santos JV; Santos-Miranda A; Roman-Campos D
    Life Sci; 2021 Feb; 267():118976. PubMed ID: 33387579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astrocytes: From the Physiology to the Disease.
    Trujillo-Estrada L; Gomez-Arboledas A; Forner S; Martini AC; Gutierrez A; Baglietto-Vargas D; LaFerla FM
    Curr Alzheimer Res; 2019; 16(8):675-698. PubMed ID: 31470787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification.
    Lauterbach EC
    Neural Regen Res; 2016 Nov; 11(11):1712-1726. PubMed ID: 28123400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical correlation between major depressive disorder and neurodegenerative diseases.
    Réus GZ; Titus SE; Abelaira HM; Freitas SM; Tuon T; Quevedo J; Budni J
    Life Sci; 2016 Aug; 158():121-9. PubMed ID: 27370938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orexinergic System in Neurodegenerative Diseases.
    Wang Q; Cao F; Wu Y
    Front Aging Neurosci; 2021; 13():713201. PubMed ID: 34483883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemically Induced Models of Parkinson's Disease: History and Perspectives for the Involvement of Ferroptosis.
    Wen S; Aki T; Unuma K; Uemura K
    Front Cell Neurosci; 2020; 14():581191. PubMed ID: 33424553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Microglia in the Development of Neurodegenerative Diseases.
    Lee JW; Chun W; Lee HJ; Kim SM; Min JH; Kim DY; Kim MO; Ryu HW; Lee SU
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases.
    Forno LS
    Ann N Y Acad Sci; 1992 May; 648():6-16. PubMed ID: 1386207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunities.
    Brem AK; Kuruppu S; de Boer C; Muurling M; Diaz-Ponce A; Gove D; Curcic J; Pilotto A; Ng WF; Cummins N; Malzbender K; Nies VJM; Erdemli G; Graeber J; Narayan VA; Rochester L; Maetzler W; Aarsland D
    Front Neurol; 2023; 14():1210974. PubMed ID: 37435159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.